Illumina (XSWX:ILMN) Interest Expense: CHF-80 Mil (TTM As of Mar. 2026)

What is Illumina Interest Expense?

Illumina XSWX:ILMN -0.79% 76 Interest Expense is CHF-80 Mil as of Mar. 2026. GuruFocus rates XSWX:ILMN with a GF Score™ of 76/100 and a GF Value™ of CHF105.51. The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Illumina's interest expense for the three months ended in Mar. 2026 was CHF -19 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-80 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Illumina's Operating Income for the three months ended in Mar. 2026 was CHF 165 Mil. Illumina's Interest Expense for the three months ended in Mar. 2026 was CHF -19 Mil. Illumina's Interest Coverage for the quarter that ended in Mar. 2026 was 8.71. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Illumina (XSWX:ILMN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Illumina's Interest Expense for the three months ended in Mar. 2026 was CHF-19 Mil. Its Operating Income for the three months ended in Mar. 2026 was CHF165 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was CHF1,547 Mil.

Illumina's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	164.546	/	-18.895
	=	8.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Illumina Interest Expense Historical Data

* Premium members only.

The historical data trend for Illumina's Interest Expense can be seen below:

Illumina Interest Expense Chart

Illumina Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-56.18

-24.22

-66.59

-89.16

-80.49

Illumina Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-22.09	-20.33	-19.90	-20.72	-18.90

76GF Score

Illumina Inc XSWX:ILMN

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Illumina Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-80 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of CHF-80 Mil mean?

Illumina (XSWX:ILMN) has a Interest Expense of CHF-80 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Illumina and its competitors.

Is Illumina's Interest Expense too high?

Illumina's current Interest Expense is CHF-80 Mil. Overall, Illumina has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.

How does Illumina's Interest Expense compare to MTD and DGX?

Illumina's Interest Expense of CHF-80 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Illumina and its competitors. Illumina's current Interest Expense is CHF-80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Illumina stock overvalued right now?

Illumina (XSWX:ILMN) has a current Interest Expense of CHF-80 Mil. The stock's GF Value™ is CHF105.51, compared to a current price of CHF143.95 — trading 36.4% above its estimated fair value. The current Interest Expense is CHF-80 Mil. Illumina's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Illumina (XSWX:ILMN), the current Interest Expense is CHF-80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Illumina (XSWX:ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of CHF143.95 is trading 36.4% above its estimated GF Value™ of CHF105.51.

Key valuation signals for XSWX:ILMN:

Interest Expense: CHF-80 Mil
GF Value™: CHF105.51 vs. price of CHF143.95 (36.4% above fair value)
GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XSWX:ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies MTD DGX LH IQV NTRA GH MEDP RVTY WAT A TMO DHR SHSE:603259 XSWX:LONN IDXX XPAR:ERF ICLR XPAR:BIM HKSE:02268 CRL

Other Exchanges ILMN:USA ILMN:Mexico 1ILMN:Italy 0J8Z:UK I1LM34:Brazil ILMN:Austria

Address 5200 Illumina Way, San Diego, CA, USA, 92122

Website https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

76GF Score

Get the complete analysis for XSWX:ILMN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF143.95

Price

CHF105.51

GF Value

View XSWX:ILMN Analysis

See Interest Expense data for all stocks →